EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C.-P.
Right arrow Articles by Shai, S.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C.-P.
Right arrow Articles by Shai, S.-E.
Related Collections
Right arrow Esophagus - cancer

Eur J Cardiothorac Surg 2001;19:10-13
© 2001 Elsevier Science NL

Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus

Chung-Ping Hsua,b, Chih-Yi Chena, Jiun-Yi Hsiaa, Sen-Ei Shaia

a Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, #160, Section 3, Taichung-Kang Road, Taichung, Taiwan
b School of Medicine, National Yang-Ming University, Taipei, Taiwan

Received 11 July 2000; received in revised form 12 October 2000; accepted 10 November 2000.

Corresponding author. Tel.: +886-4-359-2525 ext. 5050; fax: +886-4-359-9715
e-mail: cliff{at}vghtc.vghtc.gov.tw

Objectives: Current criteria of the N-category in the TNM staging system for carcinoma of the esophagus needs further subgrouping due to its simplicity in mixing together patients with different prognosis. Method: A retrospective cohort study of 186 patients (176 men and ten women; mean age, 59.9 years) with squamous cell carcinoma (SCC) of the thoracic esophagus who underwent esophagectomy followed by two-field lymphadenectomy and cervical lymph node sampling between 1992 and 1999 was conducted. A proposed N-category which involved dividing the nodal status into N0 (no nodal involvement), N1 (<=4 nodes or <=20% nodal involvement), and N2 (>4 nodes, or >20%, or non-regional nodal involvement) subgroups was used for survival analysis. Results: The overall 5-year cumulative survival rate was 27%. Lymph node metastases were identified in 101 (54.3%) patients. Cumulative survival rates were 46% at 4 years in the N0 group and 21% at 4 years in the N1 group, whereas no patients in N2 group survived longer than 3 years (P<0.01). A multivariable analysis revealed that independent prognostic factors included the depth of tumor invasion (P<0.01), nodal involvement (P<0.01), and organ metastasis (P<0.01). Conclusion: In addition to the location of nodes, the extent of nodal involvement in SCC of the thoracic esophagus also plays an important role in prognosis prediction.

Key Words: Esophagus • Carcinoma • Metastasis




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C.-S. Lin, S.-C. Chang, Y.-H. Wei, T.-Y. Chou, Y.-C. Wu, H.-C. Lin, L.-S. Wang, and W.-H. Hsu
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
Ann. Thorac. Surg., April 1, 2009; 87(4): 1056 - 1065.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.